ABSI
Absci Corporation
ABSI
Absci Corporation
Absci Corporation is upgraded to “Buy” following positive interim Phase 1 data for ABS-201 in androgenetic alopecia [AGA]. ABS-201 demonstrated an excellent PK profile, enabling infrequent dosing [2–3
Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript